ArticleThe Journal of clinical investigation2020

Autoantibodies targeting TRIM72 compromise membrane repair and contribute to inflammatory myopathy.

Kevin E McElhanon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.